Menu
Share this

Vaccine Development Expertise

Vaccine Development Therapeutic Study Experience

Delivering new vaccines to patients who need them requires a partner who understands the unique complexities presented by this important area of research. With more than 25 years of vaccine development experience for both government and commercial clients, PPD provides integrated clinical and laboratory vaccine expertise and global resources to advance our clients’ vaccine programs.


Clinical Vaccine Expertise

Our global clinical experience with clients of all sizes allows us to offer full-service capabilities and distinctive expertise across a wide spectrum of vaccine programs.

  • Early-phase vaccine development in normal healthy volunteers with safety and immunogenicity endpoints
  • Late-stage, field-efficacy studies in selected geographies and targeted populations
  • Rapid site identification and capacity to support large field-efficacy vaccine trials
  • Broad experience with cold-chain management and unique logistics of vaccine studies
  • Distinct quality control for serology specimens, including storage facilities with back-to-base centralized alarm systems to protect serum integrity

Our vast global footprint enables rapid deployment of teams to support the staffing needs of vaccine studies, including separate unblinded teams.

PPD Vaccine Development Infographic

Vaccine Sciences Lab

PPD® Laboratories vaccine sciences lab offers custom assay development, clinical testing and submission support services for new, modified and existing vaccines. Our industry-leading capabilities ensure development of innovative analytical methods and accurate, high-quality test results.

Access Special Subject Populations

PPD’ s access to global populations, coupled with our ability to run large vaccine trials, enables us to offer well-designed study plans to meet the challenges of recruiting these defined populations. PPD has experience across many target populations, including:

  • Pediatric
  • Adolescent
  • Elderly
  • Healthy normal population from disease-endemic areas with or without prior disease exposure history

For pediatric studies, we have a specialized approach for conducting assent discussions, developing appropriate literature, and educating parents and guardians to overcome possible barriers to enrollment. Our cross-functional pediatric practice area offers strategic guidance to pediatric investigational plans (PIP) and individual studies required for vaccine development.

Vaccine Development Brochure

Vaccine Services Brochure

PPD provides integrated clinical and laboratory vaccine expertise and global resources to advance our clients’ vaccine programs.

Regulatory Requirements for Clinical Development of Novel Influenza Vaccines

PPD regulatory and clinical development experts summarize the prevailing regulatory landscape for seasonal and pandemic influenza vaccines.

Contact Legal Notices Modern Slavery Transparency Statement Privacy Policy

© 2017 Pharmaceutical Product Development, LLC. All rights reserved.